Filing Details
- Accession Number:
- 0001209191-14-040013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-09 20:13:28
- Reporting Period:
- 2014-06-05
- Filing Date:
- 2014-06-09
- Accepted Time:
- 2014-06-09 20:13:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1212689 | John Hodgman | 3280 Bayshore Blvd Brisbane CA 94005 | Evp, Finance & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-06-05 | 921 | $39.66 | 23,567 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The shares sold in this transaction were acquired pursuant to a restricted stock unit grant and were sold pursuant to a pre-existing order to sell that number of shares necessary to cover the taxes owed upon the vesting of such restricted stock unit.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $39.66 to $40.16 per share. Full information on the numbers of shares sold at each sale price is available upon request.